Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-06-08

Clinical Trial Update: Effect of Vitamin D as Adjunctive Therapy in Patients With Pulmonary Evolution Tuberculosis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial examining vitamin D as adjunctive therapy for pulmonary tuberculosis; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: Instituto Nacional de Enfermedades Respiratorias | Conditions: Pulmonary Tuberculosis | Phase 4 | Status: UNKNOWN